Vironova AB - Product Pipeline Review - 2013

Date: June 30, 2013
Pages: 18
Price:
US$ 1,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: V079E5921C5EN
Leaflet:

Download PDF Leaflet

Vironova AB - Product Pipeline Review - 2013
Vironova AB - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Vironova AB - Product Pipeline Review - 2013” provides data on the Vironova AB’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Vironova AB’s corporate website, SEC filings, investor presentations and featured press releases, both from Vironova AB and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Vironova AB - Brief Vironova AB overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Vironova AB human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Vironova AB with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Vironova AB’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Vironova AB’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Vironova AB in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Vironova AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Vironova AB.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Vironova AB and identify potential opportunities in those areas.
Vironova AB Snapshot
Vironova AB Overview
Key Information
Key Facts
Vironova AB – Research and Development Overview
Key Therapeutic Areas
Vironova AB – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Vironova AB – Pipeline Products Glance
Vironova AB – Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Vironova AB – Drug Profiles
HIV-1 Program
Product Description
Mechanism of Action
R&D Progress
Influenza Drug Discovery Program
Product Description
Mechanism of Action
R&D Progress
VN-180
Product Description
Mechanism of Action
R&D Progress
Vironova AB – Pipeline Analysis
Vironova AB – Pipeline Products by Therapeutic Class
Vironova AB – Pipeline Products By Mechanism of Action
Vironova AB – Recent Pipeline Updates
Vironova AB – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Vironova AB, Key Information
Vironova AB, Key Facts
Vironova AB – Pipeline by Indication, 2013
Vironova AB – Pipeline by Stage of Development, 2013
Vironova AB – Monotherapy Products in Pipeline, 2013
Vironova AB – Discovery, 2013
Vironova AB – Pipeline By Therapeutic Class, 2013
Vironova AB – Pipeline Products By Mechanism of Action, 2013
Vironova AB – Recent Pipeline Updates, 2013

LIST OF FIGURES

Vironova AB – Pipeline by Indication, 2013
Vironova AB – Pipeline by Stage of Development, 2013
Vironova AB – Monotherapy Products in Pipeline, 2013
Vironova AB – Pipeline By Therapeutic Class, 2013
Vironova AB - Pipeline Products By Mechanism of Action, 2013

Ask Your Question

Vironova AB - Product Pipeline Review - 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: